PERFORM = Pentaglobin® Registry For Outcome Report and Monitoring
NCT03225079 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 56
Last updated 2021-02-21
Summary
International registry on the use of Pentaglobin® in patients with severe bacterial infections; multicentric, international registry, non-interventional trial
Conditions
- Severe Bacterial Infection
Sponsors & Collaborators
-
Jena University Hospital
lead OTHER
Principal Investigators
-
Frank M Brunkhorst, Prof.Dr. · Jena University Hospital, Center for Clinical Studies
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-08
- Primary Completion
- 2020-10-29
- Completion
- 2020-10-29
Countries
- Brazil
- Colombia
- Germany
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation
NCT05727917 ·Status: UNKNOWN ·Phase: NA
-
Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia
NCT02298075 ·Status: COMPLETED
-
Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women
NCT02934906 ·Status: UNKNOWN
-
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
NCT05678621 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
ITP Registry and Accompanying Biospecimen Collection
NCT05152238 ·Status: RECRUITING
-
rhTPO in Critical Patients With Thrombocytopenia
NCT02094248 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study to Reveal if Fibrinogen Treatment Effects Blood Clotting Better Than a Platelet Transfusion
NCT01955811 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Immune Thrombocytopenia Pathogenesis:
NCT02042560 ·Status: COMPLETED
-
IVIg Plus Low Dose rhTPO for ITP in Pregnancy
NCT05634824 ·Status: UNKNOWN ·Phase: PHASE2
-
Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients With Untreated Aplastic Anemia
NCT04870346 ·Status: ACTIVE_NOT_RECRUITING
-
Immune Thrombocytopenia Management in Adults
NCT05861297 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP)
NCT01162941 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days
NCT00261924 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II
NCT00861692 ·Status: COMPLETED ·Phase: PHASE2
-
The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia
NCT01869049 ·Status: WITHDRAWN
-
Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia
NCT02857530 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Study of Combined Platelet Transfusion
NCT06613425 ·Status: RECRUITING ·Phase: PHASE4
-
This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP)
NCT02859909 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational, Multicenter Study to Evaluate the Safety and Effectiveness of Hetrombopag in Patients With ITP or AA
NCT05333861 ·Status: NOT_YET_RECRUITING
-
Biologic Characterization of Patients With ITP
NCT05694325 ·Status: RECRUITING ·Phase: NA
-
Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura
NCT04056507 ·Status: COMPLETED
-
A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia
NCT02094417 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy
NCT02391272 ·Status: COMPLETED ·Phase: PHASE3
-
Severe Immune Cytopenia Registry Www.Sic-reg.Org
NCT03576742 ·Status: COMPLETED
-
Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia
NCT05018936 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3